Liquid biopsy for evaluating mutations & chromosomal aberrations in CSF from patients with primary or metastatic CNS tumors
December 10, 2024
Just published in The Journal of Liquid Biopsy Liquid biopsy for evaluating mutations and chromosomal aberrations in cerebrospinal fluid from patients with primary or metastatic CNS tumors. We’re excited to share a new paper on our CSF testing Highlights • CSF liquid biopsy (LBx) is reliable for evaluating CNS tumors.